How to Test and Treat Small Intestinal Bacterial Overgrowth: an Evidence-Based Approach

  title={How to Test and Treat Small Intestinal Bacterial Overgrowth: an Evidence-Based Approach},
  author={Ali Rezaie and Mark Pimentel and Satish S C Rao},
  journal={Current Gastroenterology Reports},
Small intestinal bacterial overgrowth (SIBO) is characterized by an excessive amount of bacteria in the small intestine and a constellation of symptoms that include bloating, pain, gas, and diarrhea. Although known for many decades, there is a lack of consensus and clarity regarding the natural history and methods for its diagnosis. Several tests have been proposed, including the glucose breath test, lactulose breath test, small intestinal aspiration and culture, and others. However, there is a… 

Testing and Treating Small Intestinal Bacterial Overgrowth Reduces Symptoms in Patients with Inflammatory Bowel Disease

This study examines the clinical effect of testing and treating for SIBO in an IBD population and sees a significant reduction in HBI after testing for and treating SIBO.

Breath Tests for the Non-invasive Diagnosis of Small Intestinal Bacterial Overgrowth: A Systematic Review With Meta-analysis

GBT seems to work better than LBT in SIBO diagnosis, and BTs demonstrate the best effectiveness in patients with surgical reconstructions of gastrointestinal tract.

Small intestinal bacterial overgrowth as a cause for irritable bowel syndrome: guilty or not guilty?

The SIBO-IBS hypothesis lacks convincing evidence but remains under scrutiny, and the mechanism resulting in symptom improvement after rifaximin treatment in some IBS individuals requires exploration.

Bacterial overgrowth: nutrition as part of the therapeutic concept Small Intestinal Bacterial Overgrowth (SIBO)

The fact that SIBO is not a primary condition, but rather a secondary caused by the pathological changes in the intestines, as described above, should be considered in all patients with the aforementioned non-specific gas-related complaints, including micronutrient deficiencies and steatorrhea.

Conventional , Complementary , and Controversial Approaches to Small Intestinal Bacterial Overgrowth

A contemporary understanding of SIBO pathophysiology, diagnosis, and therapy is outlined, with particular attention to their interface with diet and nutrition.

Small Intestinal Bacterial Overgrowth and Coronary Artery Disease: What Is in the CArDs?

It is concluded that SIBO is associated with reduced MGP activation as well as arterial stiffening, regarded as important indicators of subclinical atherosclerosis, and widely recognized risk factors for CAD were identified and adjusted for in this study.

Rifaximin for Treatment of Small Bowel Bacterial Overgrowth

  • C. Owyang
  • Medicine
    Current Trends in Gastroenterology and Hepatology
  • 2018
It was showed that restoring small bowel motility is critical in maintaining the effectiveness of Rifaximin in the treatment of SIBO, and rotation of antibiotic regimen is important to prevent drug resistance.

Small Intestinal Bacterial Overgrowth Syndrome

Small intestinal bacterial overgrowth (SIBO) is an underrecognized cause of malabsorption in the geriatric population, characterized by the excessive growth of bacteria in the small bowel, sometimes



A Systematic Review of Diagnostic Tests for Small Intestinal Bacterial Overgrowth

There is no validated diagnostic test or gold standard for SIBO, and the most practical method to evaluate SIBO in studies at this time would be a test, treat, and outcome technique.

Small Intestinal Bacterial Overgrowth Recurrence After Antibiotic Therapy

GBT positivity recurrence rate was high after antibiotic treatment, and older age, history of appendectomy, and chronic use of PPIs were associated with GBT positive recurrence.

Herbal Therapy Is Equivalent to Rifaximin for the Treatment of Small Intestinal Bacterial Overgrowth

Herbal therapies are at least as effective as rifaximin for resolution of SIBO by LBT for patients with refractory SIBO, and appear to be aseffective as triple antibiotic therapy for SIBO rescue therapy for rifaxin non-responders.

The Prevalence of Overgrowth by Aerobic Bacteria in the Small Intestine by Small Bowel Culture: Relationship with Irritable Bowel Syndrome

Using culture of the small bowel, SIBO by aerobe bacteria is independently linked with IBS, reinforcing results of clinical trials evidencing a therapeutic role of non-absorbable antibiotics for the management of IBS symptoms.

Small Intestinal Bacterial Overgrowth in Patients With Chronic Pancreatitis

The findings suggest that SIBO is not uncommon in uncomplicated CP patients and does not seem to be related to peculiar clinical features, but it might affect nutritional status.

Antibiotic therapy in small intestinal bacterial overgrowth: rifaximin versus metronidazole.

Rifaximin showed an higher SIBO decontamination rate than metronidazole at the tested doses, both with a significant gain in terms of tolerability, suggesting that rifaxim in represents a good choice for the management of patients affected by SIBO.

Small Intestinal Bacterial Overgrowth in Gastroparesis

Positive H2@90min testing by LBT was associated with increased symptoms of bloating and excessive fullness during and after meals, and no significant difference in symptom severity was seen between positive and negative DPHBT gastroparesis patients.

The place of antibiotics in management of irritable bowel syndrome: a systematic review and meta-analysis

Although antibiotics have a statistically significant effect on IBS and bloating, given the evidence for the presence of publication bias, methodological variability of the trials and lack of a precise scientific explanation for the role of bacterial overgrowth in the pathophysiology of IBS, use of antibiotics on a regular basis in IBS patients is not recommended.

Small intestinal bacterial overgrowth in rosacea: clinical effectiveness of its eradication.

  • A. ParodiS. Paolino V. Savarino
  • Medicine
    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
  • 2008

The treatment of small intestinal bacterial overgrowth with enteric-coated peppermint oil: a case report.

The results in this case suggest one of the mechanisms by which ECPO improves IBS symptoms is antimicrobial activity in the small intestine.